Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 86920 · Class III · Mississippi Valley Regional Blood Center
Key facts
| Event ID | 86920 |
|---|---|
| Recall numbers | B-0112-2021 |
| Recalling firm | Mississippi Valley Regional Blood Center |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced, Apheresis Red Blood Cells, not meeting product specifications for volume, were distributed. |
| Initiation date | Oct 21, 2020 |
| Report date | Dec 16, 2020 |
| Termination date | Dec 9, 2020 |
| City | Davenport |
| State | IA |
| Country | United States |
| FEI number | 1970356 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: